Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 1, 2011, Pages 199-207

  Johnson, Lisa G ^a   Schwartz, Stephen M ^a,b   Malkki, Mari ^c   Du, Qin ^c   Petersdorf, Effie W ^c   Galloway, Denise A ^a,b   Madeleine, Margaret M ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHROMOSOME 5; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMMUNITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POLLEN ALLERGY; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 5; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78651415463     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0779     Document Type: Article

References (36)

1. Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74-108.
2. Bosch FX, de Sanjose S. Human papillomavirus in cervical cancer. Curr Oncol Rep 2002;4:175-83.
3. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251-58.
4. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993;12:S328-S336.
5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-10.
6. Clifford GM, Polesel J, Dal Maso L, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-32.
7. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-94.
8. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005;60:1098-111.
9. Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer 2006;118:3124-32.
10. Merrill RM, Isakson RT, Beck RE. The association between allergies and cancer: what is currently known?. Ann Allergy Asthma Immunol 2007;99:102-16.
11. Montgomery SM, Ehlin AG, Sparen P, Bjorksten B, Ekblom A. Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer 2002;87:989-93.
12. Profet M. The function of allergy: immunological defense against toxins. Q Rev Biol 1991;66:23-62.
13. Burnet M. Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1957;1:841-47.
14. Mackay WD. The incidence of allergic disorders and cancer. Br J Cancer 1966;20:434-37.
15. Eriksson NE, Holmen A, Hogstedt B, Mikoczy Z, Hagmar L. A prospective study of cancer incidence in a cohort examined for allergy. Allergy 1995;50:718-22.
16. Markiewicz MA, Gajewski TF. The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncog 1999;10:247-60.
17. Castaing M, Youngson J, Zaridze D, et al. Is the risk of lung cancer reduced among eczema patients?Am J Epidemiol 2005;162:542-47.
18. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 2006;18:738-44.
19. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010;38:D355-D360.
20. Gilles S, Mariani V, Bryce M, et al. Pollen allergens do not come alone: pollen associated lipid mediators PALMS shift the human immune systems towards a TH2-dominated response. Allergy Asthma Clin Immunol 2009;5:3.
21. Loose D, Van de Wiele C. The immune system and cancer. Cancer Biother Radiopharm 2009;24:369-76.
22. Cormier SA, Taranova AG, Bedient C, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006;79:1131-39.
23. Mattes J, Hulett M, Xie W, et al. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 2003;197:387-93.
24. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004;59:268-75.
25. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996;5:541-48.
26. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-21.
27. Kbiosciences KASPar genotyping method [Internet]. [cited 2010 Oct 26]. Available from: http://www.kbioscience.co.uk/lab%20services/SNP%20Genotyping/ genotyping-chemistry.html.
28. Daling JR, Madeleine MM, Schwartz SM, et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-70.
29. Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics 1979;6:65-70.
30. Beghe B, Hall IP, Parker SG, et al. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy 2010;65:474-81.
31. Black S, Teixeira AS, Loh AX, et al. Contribution offunctional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy 2009;64:1172-78.
32. Arbes SJ Jr., Gergen PJ , Elliott L , Zeldin DC . Prevalences ofpositive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377-83.
33. IvanssonEL,RasmussenF,GyllenstenUB,MagnussonPK. Reduced incidence of cervical cancer in mothers of sons with allergic rhinoconjunctivitis, asthma or eczema. Int J Cancer 2006;119:1994-98.
34. Sherman PW, Holland E, Sherman JS. Allergies: their role in cancer prevention. Q Rev Biol 2008;83:339-62.
35. Magone MT, Whitcup SM, Fukushima A, Chan CC, Silver PB, Rizzo LV. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J Allergy Clin Immunol 2000;105:299-308.
36. Cohen S. Cytokine profile data. Imm unol Today 2000;21:199-200.